Bachem expands capacity to meet peptide, oligonucleotide demand
The Switzerland-headquartered CDMO is investing about $618 million in a greenfield project in Sisslerfeld, while ramping up Building K operations in Bubendorf.
Read the full article on the original site.
Read Full Article